Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses. (September 2021)

Record Type:: Journal Article
Title:: Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses. (September 2021)
Main Title:: Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses
Authors:: Joseph, Jeswin
Karthika, T.
Das, V.R. Akshay
Raj, V. Stalin
Abstract:
Is Part Of:: Journal of global antimicrobial resistance. Volume 26(2021)
Journal:: Journal of global antimicrobial resistance
Issue:: Volume 26(2021)
Issue Display:: Volume 26, Issue 2021 (2021)
Year:: 2021
Volume:: 26
Issue:: 2021
Issue Sort Value:: 2021-0026-2021-0000
Page Start:: 26
Page End:: 28
Publication Date:: 2021-09
Subjects:: Drug resistance -- Periodicals
Drug resistance -- Periodicals
Drug resistance
Periodicals
616.9041
Journal URLs:: http://www.sciencedirect.com/science/journal/22137165 ↗
http://www.sciencedirect.com/ ↗
http://www.bibliothek.uni-regensburg.de/ezeit/?2710046 ↗
http://www.elsevier.com/locate/jgar ↗
DOI:: 10.1016/j.jgar.2021.05.005 ↗
Languages:: English
ISSNs:: 2213-7165
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 19600.xml